tiprankstipranks
Trending News
More News >
Sharda Cropchem Ltd. (IN:SHARDACROP)
:SHARDACROP
India Market
Advertisement

Sharda Cropchem Ltd. (SHARDACROP) AI Stock Analysis

Compare
2 Followers

Top Page

IN:SHARDACROP

Sharda Cropchem Ltd.

(SHARDACROP)

Select Model
Select Model
Select Model
Outperform 73 (OpenAI - 4o)
Rating:73Outperform
Price Target:
₹961.00
▲(18.03% Upside)
Sharda Cropchem Ltd. scores well due to its strong financial performance, characterized by revenue and net income growth, and a solid balance sheet. The technical analysis presents mixed signals, with short-term strength but potential bearish momentum. Valuation metrics indicate a fair market price, with a reasonable P/E ratio and moderate dividend yield.
Positive Factors
Revenue Growth
Strong revenue growth indicates robust market demand and effective sales strategies, enhancing long-term earnings potential.
Balance Sheet Health
A solid balance sheet with low leverage provides financial stability and flexibility for future investments and growth.
Cash Flow Generation
Effective cash management and operational efficiency ensure the company can fund operations and strategic initiatives sustainably.
Negative Factors
EBITDA Margin
Suboptimal EBITDA margin suggests potential inefficiencies in cost management, which could impact profitability if not addressed.
Asset Utilization
Inefficient asset utilization can limit operational efficiency and growth, necessitating strategic improvements to optimize resources.
Free Cash Flow Allocation
Suboptimal free cash flow allocation could hinder capital expenditure and growth investments, affecting long-term strategic goals.

Sharda Cropchem Ltd. (SHARDACROP) vs. iShares MSCI India ETF (INDA)

Sharda Cropchem Ltd. Business Overview & Revenue Model

Company DescriptionSharda Cropchem Ltd. (SHARDACROP) is a prominent player in the agrochemical sector, specializing in the production and distribution of a diverse range of crop protection chemicals, including pesticides, herbicides, and fungicides. Established in India, the company has expanded its operations globally, serving agricultural markets across various regions. Sharda Cropchem is known for its commitment to quality and innovation, with a portfolio that caters to both conventional agriculture and the growing demands for sustainable farming solutions.
How the Company Makes MoneySharda Cropchem generates revenue primarily through the sale of its agrochemical products, which include a wide array of formulations tailored to different agricultural needs. The company operates on a business model that encompasses both manufacturing and trading, allowing it to leverage economies of scale in production while also capitalizing on market opportunities through trading activities. Key revenue streams include direct sales to agricultural producers, distribution agreements with local dealers, and exports to international markets. Additionally, Sharda Cropchem has established significant partnerships with various agricultural firms and research institutions, enhancing its product development capabilities and market reach, thereby contributing to its overall earnings.

Sharda Cropchem Ltd. Financial Statement Overview

Summary
Sharda Cropchem Ltd. demonstrates strong financial performance with impressive revenue and net income growth, a solid balance sheet with low debt levels, and robust cash flow generation. However, there is room for improvement in EBITDA margin and asset utilization.
Income Statement
85
Very Positive
Sharda Cropchem Ltd. exhibits strong revenue growth with a notable increase from the previous year, highlighting its robust market position in the Agricultural Inputs industry. The company has achieved a high gross profit margin, indicating efficient cost management. The net profit margin has improved significantly, reflecting enhanced profitability. However, EBITDA margin shows some room for improvement compared to EBIT, suggesting potential cost optimization opportunities.
Balance Sheet
80
Positive
The company maintains a solid balance sheet with a low debt-to-equity ratio, indicating prudent leverage management. The equity ratio is strong, showcasing a healthy capital structure. Return on Equity (ROE) is commendable, driven by increased net income. The company's financial stability is evident, although further enhancement in asset utilization could improve overall efficiency.
Cash Flow
78
Positive
Sharda Cropchem Ltd. demonstrates significant free cash flow growth, underscoring effective cash management and operational efficiency. The operating cash flow to net income ratio is strong, indicating a solid conversion of income into cash. However, the free cash flow to net income ratio suggests potential areas for cash allocation improvement, particularly in capital expenditure management.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue45.20B43.20B31.61B40.45B35.76B23.91B
Gross Profit14.12B12.92B8.18B11.84B10.76B7.55B
EBITDA8.07B6.13B3.43B6.99B7.25B4.96B
Net Income4.20B3.04B318.83M3.42B3.49B2.29B
Balance Sheet
Total Assets0.0047.25B40.38B43.51B37.43B28.64B
Cash, Cash Equivalents and Short-Term Investments5.57B5.57B3.74B2.13B1.96B1.71B
Total Debt0.0077.60M183.00M29.65M466.48M807.57M
Total Liabilities-25.01B22.24B18.01B21.18B18.30B12.49B
Stockholders Equity25.01B25.01B22.37B22.32B19.12B16.14B
Cash Flow
Free Cash Flow0.006.03B692.08M842.03M333.12M151.70M
Operating Cash Flow0.006.04B3.41B3.28B2.67B2.46B
Investing Cash Flow0.00-5.10B-3.93B-1.45B-2.08B-2.82B
Financing Cash Flow0.00-679.32M-369.10M-971.01M-909.56M433.51M

Sharda Cropchem Ltd. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price814.20
Price Trends
50DMA
830.61
Positive
100DMA
886.54
Negative
200DMA
754.93
Positive
Market Momentum
MACD
-3.88
Negative
RSI
59.36
Neutral
STOCH
77.84
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:SHARDACROP, the sentiment is Positive. The current price of 814.2 is above the 20-day moving average (MA) of 796.37, below the 50-day MA of 830.61, and above the 200-day MA of 754.93, indicating a bullish trend. The MACD of -3.88 indicates Negative momentum. The RSI at 59.36 is Neutral, neither overbought nor oversold. The STOCH value of 77.84 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:SHARDACROP.

Sharda Cropchem Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
₹73.13B16.191.10%33.23%107.47%
70
Outperform
₹72.90B12.973.58%-7.53%42.74%
68
Neutral
₹73.88B11.062.70%15.25%26.49%
62
Neutral
₹84.27B29.460.93%-3.19%59.25%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
60
Neutral
₹44.60B26.570.15%21.67%25.86%
56
Neutral
₹50.89B28.920.95%0.91%18.12%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:SHARDACROP
Sharda Cropchem Ltd.
871.15
58.20
7.16%
IN:GNFC
Gujarat Narmada Valley Fertilizers & Chemicals Ltd.
502.20
-128.99
-20.44%
IN:GSFC
Gujarat State Fertilizers & Chemicals Limited
185.40
-36.95
-16.62%
IN:RALLIS
Rallis India Limited
264.25
-63.98
-19.49%
IN:RCF
Rashtriya Chemicals & Fertilizers Ltd.
139.85
-35.31
-20.16%
IN:REFEX
Refex Industries Limited
336.80
-209.82
-38.38%

Sharda Cropchem Ltd. Corporate Events

Sharda Cropchem Ensures Regulatory Compliance with SEBI Certificate Submission
Oct 4, 2025

Sharda Cropchem Ltd. has submitted a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ending September 30, 2025. This submission, certified by KFin Technologies Limited, confirms the dematerialization and rematerialization of securities during the specified period, ensuring compliance with regulatory requirements and maintaining transparency with stock exchanges.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 30, 2025